These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

815 related items for PubMed ID: 7727055

  • 1. Drug-induced torsade de pointes. Incidence, management and prevention.
    Faber TS, Zehender M, Just H.
    Drug Saf; 1994 Dec; 11(6):463-76. PubMed ID: 7727055
    [Abstract] [Full Text] [Related]

  • 2. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S, Rao ML, Schröder R, Lüderitz B, Bauriedel G.
    Dtsch Med Wochenschr; 2001 Dec 07; 126(49):1396-400. PubMed ID: 11740632
    [Abstract] [Full Text] [Related]

  • 3. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB.
    Circulation; 1992 Nov 07; 86(5):1376-82. PubMed ID: 1423949
    [Abstract] [Full Text] [Related]

  • 4. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L, Abrahamsson C, Andersson B, Duker G, Schiller-Linhardt G.
    Cardiovasc Res; 1993 Dec 07; 27(12):2186-93. PubMed ID: 8313427
    [Abstract] [Full Text] [Related]

  • 5. Drug therapy for torsade de pointes.
    Banai S, Tzivoni D.
    J Cardiovasc Electrophysiol; 1993 Apr 07; 4(2):206-10. PubMed ID: 8269292
    [Abstract] [Full Text] [Related]

  • 6. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC, Morton BC, Green MS, Tang AS.
    Can J Cardiol; 1997 Apr 07; 13(4):383-6. PubMed ID: 9141970
    [Abstract] [Full Text] [Related]

  • 7. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM, Leunissen JD, Wellens HJ, Vos MA.
    Eur J Pharmacol; 2001 Jan 19; 412(1):67-76. PubMed ID: 11166738
    [Abstract] [Full Text] [Related]

  • 8. Drug-induced torsade de pointes.
    Raehl CL, Patel AK, LeRoy M.
    Clin Pharm; 1985 Jan 19; 4(6):675-90. PubMed ID: 2416504
    [Abstract] [Full Text] [Related]

  • 9. Torsade de pointes induced by ajmaline.
    Haverkamp W, Mönnig G, Kirchhof P, Eckardt L, Borggrefe M, Breithardt G.
    Z Kardiol; 2001 Aug 19; 90(8):586-90. PubMed ID: 11565214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R.
    Eur Heart J; 1993 Nov 19; 14 Suppl H():88-92. PubMed ID: 8293758
    [Abstract] [Full Text] [Related]

  • 12. [Iatrogenic torsade de pointes induced by thioridazine].
    Paoloni P, Ciliberti D, Blasi N, Capone P.
    Minerva Cardioangiol; 1992 Jun 19; 40(6):245-9. PubMed ID: 1407620
    [Abstract] [Full Text] [Related]

  • 13. [Drug induced QT prolongation].
    Altmann D, Eggmann U, Ammann P.
    Wien Klin Wochenschr; 2008 Jun 19; 120(5-6):128-35. PubMed ID: 18365152
    [Abstract] [Full Text] [Related]

  • 14. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS, Zehender M, Van de Loo A, Hohnloser S, Just H.
    Clin Cardiol; 1994 Apr 19; 17(4):197-202. PubMed ID: 8187370
    [Abstract] [Full Text] [Related]

  • 15. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA, Zheutlin TA, Sarmiento JJ, Parker M, Lesch M, Kehoe RF.
    Ann Intern Med; 1989 Oct 01; 111(7):574-80. PubMed ID: 2774388
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiologic parameters and predisposing factors in the generation of drug-induced Torsade de Pointes arrhythmias.
    Vos MA, van Opstal JM, Leunissen JD, Verduyn SC.
    Pharmacol Ther; 2001 Oct 01; 92(2-3):109-22. PubMed ID: 11916532
    [Abstract] [Full Text] [Related]

  • 17. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W, Wichter T, Chen X, Hördt M, Willems S, Rotman B, Hindricks G, Kottkamp H, Borggrefe M, Breithardt G.
    Z Kardiol; 1994 Oct 01; 83 Suppl 5():75-85. PubMed ID: 7846949
    [Abstract] [Full Text] [Related]

  • 18. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
    Silvetti MS, Drago F, Bevilacqua M, Ragonese P.
    Ital Heart J; 2001 Mar 01; 2(3):231-6. PubMed ID: 11305536
    [Abstract] [Full Text] [Related]

  • 19. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR, Yan GX, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2013 Mar 01; 68(2):250-259. PubMed ID: 23337247
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.